Table 3.

Treatment outcomes at discharge.

Outcomes	NACa (n=68)	Non-NAC (n=60)	P value
Hospital stay (d), mean (SD)	5.01 (1.28)	6.12 (1.25)	<.001
Posttreatment ASTb (U/L), mean (SD)	154.83 (67.22)	184.62 (79.88)	.02
Posttreatment ALTc (U/L), mean (SD)	113.09 (33.31)	156.35 (73.66)	.004
ΔAST (U/L), mean (SD)	454.85 (261.85)	326.91 (170.44)	.002
ΔALT (U/L), mean (SD)	312.03 (154.21)	263.62 (153.99)	.08
Posttreatment platelet count (G/L), median (IQR)	31.50 (19.00-50.15)	17.00 (8.75-36.23)	.001
Change in platelet count (G/L), median (IQR)	15.05 (7.05-26.10)	6.95 (4.22-15.43)	.001

^aNAC: N-acetylcysteine.

^bAST: aspartate aminotransferase.

^cALT: alanine aminotransferase.